Matches in Wikidata for { <http://www.wikidata.org/entity/Q73886823> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q73886823 description "article scientifique publié en 1999" @default.
- Q73886823 description "artículu científicu espublizáu n'avientu de 1999" @default.
- Q73886823 description "im Dezember 1999 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73886823 description "scientific article published on 01 December 1999" @default.
- Q73886823 description "wetenschappelijk artikel" @default.
- Q73886823 description "наукова стаття, опублікована в грудні 1999" @default.
- Q73886823 name "Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy" @default.
- Q73886823 name "Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy" @default.
- Q73886823 type Item @default.
- Q73886823 label "Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy" @default.
- Q73886823 label "Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy" @default.
- Q73886823 prefLabel "Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy" @default.
- Q73886823 prefLabel "Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy" @default.
- Q73886823 P1433 Q73886823-009CDF7D-F8A1-4983-BE2D-3EA6B9B91281 @default.
- Q73886823 P1476 Q73886823-93E180AE-B62E-4A83-8EDA-3E5653F084F3 @default.
- Q73886823 P2093 Q73886823-04ECB272-E7CF-4595-AAD0-86364133CB06 @default.
- Q73886823 P2093 Q73886823-0A9CF4BF-30C5-4B68-BCE7-E8B7BEDE2076 @default.
- Q73886823 P2093 Q73886823-203F5B12-CA4F-4917-B2B0-CA25C91FF8ED @default.
- Q73886823 P2093 Q73886823-9746E4C8-D8CA-4469-AA3C-03F76797A5D6 @default.
- Q73886823 P304 Q73886823-02DE3430-68BE-4037-8DDE-39649D4AC4B1 @default.
- Q73886823 P31 Q73886823-963A9F5E-EBDC-480E-A8CC-407D5D7A596D @default.
- Q73886823 P433 Q73886823-0DECA895-ADAA-4763-ABA4-7F78B269CD05 @default.
- Q73886823 P478 Q73886823-391DE6C1-14B6-4162-A474-2F17A2993863 @default.
- Q73886823 P577 Q73886823-C4D4F8C9-02E6-4661-81F3-6A94DBC2C4FD @default.
- Q73886823 P698 Q73886823-934831D7-7A43-4C22-8E64-7767C670615A @default.
- Q73886823 P921 Q73886823-B76F59D3-620C-4BA6-B7B4-C1442182AD79 @default.
- Q73886823 P698 10850383 @default.
- Q73886823 P1433 Q27714262 @default.
- Q73886823 P1476 "Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy" @default.
- Q73886823 P2093 "Chapman PB" @default.
- Q73886823 P2093 "Klimek VM" @default.
- Q73886823 P2093 "Williams L" @default.
- Q73886823 P2093 "Wolchok JD" @default.
- Q73886823 P304 "205-206" @default.
- Q73886823 P31 Q13442814 @default.
- Q73886823 P433 "4" @default.
- Q73886823 P478 "5" @default.
- Q73886823 P577 "1999-12-01T00:00:00Z" @default.
- Q73886823 P698 "10850383" @default.
- Q73886823 P921 Q18975855 @default.